Page last updated: 2024-10-21

4-(2-aminoethyl)benzenesulfonylfluoride and Lung Diseases, Interstitial

4-(2-aminoethyl)benzenesulfonylfluoride has been researched along with Lung Diseases, Interstitial in 1 studies

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research Excerpts

ExcerptRelevanceReference
" TNF bioavailability is regulated partly by TNF-alpha converting enzyme (TACE) cleavage; however, it can also be cleaved by proteinase-3 (PR-3)."1.35Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3. ( Armstrong, L; Godinho, SI; Millar, AB; Uppington, KM; Whittington, HA, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, L1
Godinho, SI1
Uppington, KM1
Whittington, HA1
Millar, AB1

Other Studies

1 other study available for 4-(2-aminoethyl)benzenesulfonylfluoride and Lung Diseases, Interstitial

ArticleYear
Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.
    Clinical and experimental immunology, 2009, Volume: 156, Issue:2

    Topics: ADAM Proteins; ADAM17 Protein; Adult; Aged; Aged, 80 and over; Analysis of Variance; Blotting, Weste

2009